24 October 2024

Exploring Tumour-Body Interactions: Highlights from #CRSy24

With nearly 30 presenters—including 4 keynote speakers—ranging from internationally renowned scientists to emerging researchers, the symposium was structured into eight thematic sessions, each exploring different dimensions, from the interplay between tumour cells and their microenvironment to the systemic impacts of cancer on the body.

Robert Bravo

Miguel Gomes

Miguel Chaves Ferreira

Beatriz Lourenço

Luísa CastelBranco Silva

16 October 2024

Alzheimer’s: each case is a case on its own

“I’m exactly as I was 10 years ago”, says Kina García, a Spanish woman from the Granada region, as she addresses by Zoom, from her home, the audience of the International Conference on Neurodegenerative Diseases, gathered on a Saturday morning at the Champalimaud Foundation’s auditorium, in Lisbon. The date is appropriate: it is September 21 – World Alzheimer's Day. 

André Abreu

Moving Beyond 2025

This 2-day conference organised by the Champalimaud Foundation, in partnership with Faculdade de Motricidade Humana, will provide an overview of the scientific landscape in the area of physical activity and cancer, from prevention to rehabilitation and survivorship.

These are exciting times for research in this space as physical activity becomes more widely recognised as a powerful partner in the prevention and treatment of cancer.

11 October 2024

Champalimaud Foundation Ranks 11th Worldwide and 5th in Europe in Global Neuroscience Research Among Non-Profit Institutions

Joining institutions such as the Max Planck Society, Germany (#1), the Allen Institute, USA (#6), and the Pasteur Institute, France (#13), the CF's ranking places it among the world’s top contributors to neuroscience, and as the only Portuguese institution to make the list. The ranking is based on its contribution to published research, which is measured by both the number of articles (“Count”) and the portion of authorship (“Share”).

Subscribe to Champalimaud Research
Loading
Please wait...